| JYHZ2100668 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | License Renew | 2021-10-22 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH;Pfizer Investment Co Ltd | | | view |
| JYHZ2100667 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | License Renew | 2021-10-22 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH;Pfizer Investment Co Ltd | | | view |
| JYHZ1600301 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | License Renew | 2016-12-06 | 辉瑞制药有限公司 | Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Manufacturing Deutschland GmbH;Pfizer Ltd | Certificate Issued | 2018-01-11 | view |
| JYHZ1600300 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | License Renew | 2016-12-06 | 辉瑞制药有限公司 | Viatris Pharmaceuticals (Dalian) Co Ltd;Pfizer Manufacturing Deutschland GmbH;Pfizer Ltd | Certificate Issued | 2018-01-11 | view |
| JYHB2300740 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2023-12-22 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2300739 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2023-12-22 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2200477 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2022-09-03 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2200476 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2022-09-03 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2200052 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2022-01-26 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2200051 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2022-01-26 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2200048 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2022-01-24 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2200047 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2022-01-24 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2101570 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2021-12-07 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2101569 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2021-12-07 | | Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | | | view |
| JYHB2100169 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2021-03-02 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | In Review | 2021-03-01 | view |
| JYHB2100168 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2021-03-02 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | In Review | 2021-03-01 | view |
| JYHB2002271 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-11-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | Filed | 2020-12-01 | view |
| JYHB2002270 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-11-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | Filed | 2020-12-01 | view |
| JYHB2001752 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-09-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | Filed | 2020-09-27 | view |
| JYHB2001751 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-09-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Manufacturing Deutschland GmbH | Filed | 2020-09-27 | view |
